Intrathecal baclofen therapy for spastic hypertonia

Physical Medicine and Rehabilitation Clinics of North America

Volumn 12, Issue 4, 2001, Pages 923-938

  Ivanhoe, C B ^a   Tilton, A H ^a   Francisco, G E ^a  

^a TIRR MEMORIAL HERMANN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN;

CEREBRAL PALSY; CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; FOLLOW UP; HEADACHE; HUMAN; INFUSION PUMP; MUSCLE HYPERTONIA; PATIENT EDUCATION; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SPASTICITY;

EID: 0035150093     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1047-9651(18)30039-1     Document Type: Review

References (57)

1. Baclofen in the treatment of cerebral palsy
2. Intrathecal baclofen in cerebral palsy movement disorders
3. Continuous intrathecal baclofen infusion for spasticity of cerebral origin
4. Intrathecal baclofen for spasticity in cerebral palsy
5. Continuous intrathecal baclofen infusion for symptomatic generalized dystonia
6. Effects of continuous intrathecal baclofen infusion and selective posterior rhizotomy on upper extremity spasticity
7. Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen
8. Intrathecally administered baclofen infusion for treatment of children with spasticity of cerebral origin
9. Intrathecal baclofen administration for control of severe spasticity: Functional improvement and long term follow up
10. Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury
11. Measurement of the effect of a bolus dose of intrathecal baclofen by a repetitive movement test
12. Chronic intrathecal baclofen administration in severe spasticity
13. The effects of intrathecally administered baclofen on function in patients with spasticity
14. Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long term multicenter study
15. Effects of quadriceps strengthening in crouch gait in children with spastic diplegia
16. Intrathecal baclofen normalizes motor strategy for squatting in familial spastic paraplegia: A case study
17. Pregnancy in a quadriplegic patient treated with continuous intrathecal baclofen infusion to manage her severe spasticity: Case report
18. Quantitative assessment of intrathecally administered baclofen in spasticity
19. The effect of intrathecal baclofen therapy on walking speed of individuals with post stroke hemiplegia
20. Pseudomonas aeruginosa infection in an intrathecal baclofen pump: Successful treatment with adjunct intra-reservoir gentamicin
21. Effect on ambulation of continuous intrathecal baclofen infusion
22. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with cerebral palsy
23. Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial
24. Management of spasticity in children: Part 2: Oral medications and intrathecal baclofen
25. Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity
26. Death after acute withdrawal of intrathecal baclofen: Case report and literature review
27. Treatment alternatives for spinal cord injury related spasticity
28. Drugs used to treat spasticity
29. Epileptic seizures associated with intrathecal baclofen application
30. Changes in voluntary motor control induced by intrathecal baclofen in patients with spasticity of different etiology
31. Effects of intrathecal baclofen on voluntary motor control in spastic paresis
32. Continuous infusion of intrathecal baclofen: Long term effects on spasticity in spinal cord injury
33. Intrathecal baclofen for intractable spasticity in amyotrophic lateral sclerosis
34. Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury
35. Long term continuously infused baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1 Year experience
36. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia
37. Intrathecal baclofen in spinal cord spasticity
38. Intrathecal baclofen therapy in hereditary spastic paraparesis
39. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity
40. A controlled trial of baclofen in children with cerebral palsy
41. Treatment of severe spasticity: Results of a multicenter trial conducted in Germany involving the intrathecal infusion of baclofen by an implantable drug delivery system
42. Effect of intrathecal baclofen on bladder and sphincter function
43. Intrathecal baclofen for spasticity of cerebral origin: Cerebral palsy and brain injury
44. Intrathecal baclofen for long-term treatment of spasticity: A multicentre study
45. Functional outcome after delivery of intrathecal baclofen
46. Intrathecal baclofen for motor disorders
47. Intrathecal baclofen alleviates spinal cord spasticity
48. Intrathecal baclofen for severe spinal spasticity
49. Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump; long term follow-up review of 18 patients
50. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal
51. Transient paralysis after intrathecal baclofen for the treatment of post-selective dorsal rhizotomy pain in children
52. Cost analysis of continuous intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy
53. Intrathecal baclofen for intractable cerebral spasticity: A prospective placebo-controlled, double blind study
54. Spasticity in children with cerebral palsy: A retrospective review of the effects of intrathecal baclofen
55. Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pump associated meningitis